CSB601 Chap.3 Drug Interactions, Older Adults and Pregnancy
Drug Interactions, Older Adults and Pregnancy
Classifying and judging interactions
Interactions either change drug levels, through enzyme inhibition or induction, or change the effect at a given level, through additive or synergistic action.
The MESS framework (mechanism, evidence, severity, symptoms and monitoring) turns a database alert into a clinical judgement, and checking more than one resource exposes disagreements between them.
Two populations that need extra care
Older adults bring declining renal function, heightened sensitivity to CNS-active drugs and frequent polypharmacy, which together raise the risk of falls, confusion and admission.
Pregnancy adds fetal risk that depends on timing, dose and placental transfer, and Australia grades medicines with categories A, B1, B2, B3, C, D and X. Each category has a precise definition and caveats worth memorising word for word.
What this chapter covers
- 01
Pharmacokinetic Versus Pharmacodynamic Interactions
- 02
MESS Framework for Interaction Alerts
- 03
Age-Related PK and PD Changes
- 04
Polypharmacy, Falls and Deprescribing
- 05
Australian Pregnancy Categories
- 06
Teratogenic Timing and Placental Transfer
Worked example · free
Planning pregnancy on a Category D anticonvulsant
- 2Interpret the category: Category D medicines have caused or may cause malformations or irreversible damage, yet the category is not an absolute contraindication, and anticonvulsants are the standard example. Weigh the risks and benefits of treating against not treating, for mother and fetus.
- 2Plan before conception: review the regimen with the prescriber while she is not yet pregnant, start folic acid before conception as advised for anticonvulsants such as sodium valproate, and aim for the lowest effective dose.
- 2Use specialist, independent resources such as the Pregnancy and Breastfeeding Medicines Guide, the TGA database and a state medicines information service rather than MIMS alone, then document a shared decision and monitor through pregnancy and the postnatal period.
Key terms
- Enzyme Induction
- An increase in metabolising enzyme activity caused by another drug, lowering levels and therapeutic effect of the affected medicine.
- Enzyme Inhibition
- A reduction in metabolising enzyme activity caused by another drug, raising levels and toxicity risk of the affected medicine.
- Teratogenic Exposure
- Contact with an exogenous agent that can modify embryonic or fetal functional or structural development.
- Deprescribing
- The planned and supervised reduction or cessation of a medicine that may be causing harm or is no longer of benefit.
- Polypharmacy
- The use of multiple medicines, with five or more regarded as sharply raising the risk of adverse effects and interactions.
Drug Interactions, Older Adults and Pregnancy FAQ
If a database labels an interaction as severe, must one of the medicines be stopped?
Not necessarily. A severe rating is a prompt to think: assess the individual risk, decide what to monitor, and compare safer alternatives. Many flagged combinations continue with closer monitoring or a dose change. Check whether other references agree on the rating, because eMIMSelite, AusDI and AMH may describe the same pair differently.
Is a Category B medicine safer in pregnancy than a Category C medicine?
Not by definition. B subcategories rest on limited human use plus animal data, while C describes pharmacological effects on the fetus or neonate that may be reversible. The lecture states plainly that B does not imply greater safety than C. Only Category A, backed by large numbers of pregnant women, is described as having a better safety profile than every other category.
Why are older people more affected by sedatives and pain medicines?
Ageing changes both pharmacokinetics and pharmacodynamics. Reduced kidney function slows removal of renally excreted drugs, while altered receptors and weaker compensatory reflexes heighten CNS effects of benzodiazepines and opioids. Slow elimination can carry drowsiness into the next day, raising falls risk. Lower starting doses and gradual titration are therefore recommended.
Where should I look up whether a medicine is safe in pregnancy?
Specialist Australian resources come first: the Pregnancy and Breastfeeding Medicines Guide from the Royal Women's Hospital, the TGA prescribing medicines in pregnancy database, Therapeutic Guidelines and state medicines information services. AMH monographs add limited detail. Product information such as MIMS is often conservative and quotes animal data, so it should not be your only source.
Exam move
Build a two-column comparison card for pharmacokinetic and pharmacodynamic interactions, adding the warfarin examples taught in the unit, and rehearse saying which column a new pair belongs to within ten seconds. Then practise MESS on two or three medicine pairs using eMIMSelite, AusDI and AMH, noting where the ratings disagree, because explaining a disagreement shows deeper understanding than copying one alert.
For older adults, write the start low, go slow sequence from memory and list the medicine groups linked to falls, confusion and hypoglycaemia. For pregnancy, copy each category definition onto a separate flashcard with its caveat on the back, and test yourself on the B versus C and Category D traps.
Finish by drafting a short answer that weighs treating against not treating for a pregnant patient, since risk versus benefit reasoning recurs across both the pregnancy and the older-adult lectures.
Working through Drug Interactions, Older Adults and Pregnancy in CSB601? Sia is AskSia’s AI Pharmacy tutor — ask any CSB601 Drug Interactions, Older Adults and Pregnancy question and get a clear, step-by-step explanation grounded in how CSB601 is taught and assessed. Read this chapter free, then take your hardest questions to Sia.
